IL17A and rheumatoid arthritis: Consistent with the role of the Th17/IL-17 axis in the pathogenesis of RA, patients with severe disease exhibit elevated frequencies of Th17 cells, and clinical responses to TNFα inhibitors in autoimmune subjects have been associated with reductions in circulating Th17 cells[4,5].